Lung Cancer Update.
In: PharmaWatch: Cancer, Jg. 7 (2008-05-01), Heft 5, S. 15-15
report
Zugriff:
The article reports developments related to lung cancer. Celgene Corp.'s amrubicin has been granted orphan drug designation for the treatment of lung cancer. European Medicines Agency (EMEA) will review the marketing authorization application for Xyotax from Cell Therapeutics Inc. for the treatment of non-small cell lung cancer. Eli Lilly & Co. has won an approval from European health authorities regarding the use of Alimta for the treatment of lung cancer.
Titel: |
Lung Cancer Update.
|
---|---|
Zeitschrift: | PharmaWatch: Cancer, Jg. 7 (2008-05-01), Heft 5, S. 15-15 |
Veröffentlichung: | 2008 |
Medientyp: | report |
Schlagwort: |
|
Sonstiges: |
|